Compagnie Lebon Stocks

101.5Last Updated 24.04.2026

Issuer Rating

3/7
Performance

Average

Risk

Considerable

Recommendation

Sell

Market Cap

€ 136.69M

Buy
Review
Evaluation
Target price
Dynamics
Performance
Growth
Dividends
Risks
101.5
Key Takeaways

Risk factor

Very poor trading liquidity

Data is available to registered users only
Data is available to registered users only

Profitability factor

Favourable analyst view

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Compagnie Lebon engages in the hotel, private equity, real estate, and thermal bath businesses in France. It engages in the acquisition of the majority or minority stakes in the capital of unlisted small and medium-sized companies; and real estate valuation business. The company is also involved in the acquisition, renovation, management, and operation of hotels; and operates thermal baths and spas under the Brides-les-Bains, Salins-les-Thermes, and Allevard names, as well as two hotels in Brides-les-Bains. As of December 31, 2021, it operated 13 hotels. The company was incorporated in 1847 and is headquartered in Paris, France. Compagnie Lebon is a subsidiary of France Participations SA.

Company Valuation

Slightly overvalued
3/7

Based on key historical and expected multiples, the stock is slightly overvalued relative to its peers. In particular, the stock is overpriced on P/E, of fair value on EV

Data is available to registered users only
Sign up to access detailed valuation

Target Price

Favourable
6/7

The average target price of ALBON.PA is 148 and suggests 44% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc

Data is available to registered users only
Sign up to access analyst forecasts

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis
X-channel

Buy

Sell

0 more stocks